XMax, anchored by its premium furniture brand Diamond Sofa, is evolving through a forward-looking commitment to global progress. With a portfolio featuring SpaceX, xAI, and Neuralink, we are shaping a comprehensive investment ecosystem dedicated to the technologies that will define our future. XMax conducts rigorous evaluations of technological potential and breakthrough capabilities to identify and invest in frontier technology companies worldwide—those poised to redefine industry paradigms and advance human civilization. Our portfolio is not a mere collection of companies, but a systematically designed ecosystem of future-defining technologies. Investment Strategy:Value investing in humanity’s future technologies with a long-term horizon and diversified risk exposure.
Founded in 2002,SpaceX is redefning humanity'srelationship with space through reusable rockets and theStarlink satellite network. More than a rocket company,it is also a communications and interplanetaryinfrastructure enterprise forming the foundation of thenext generation of civilization Latest Valuation: $400B+ Core Businesses: Falcon rockets, Starlink, Starship, Crew Dragon spacecraft Future Highlights: Starlink lPO, Mars colonizationprogram, dominant position in global broadbandinfrastructure
Founded in 2023, xAI's mission is to “understand the true nature of the universe.” In just one year, it launched Grok AI and deeply integrated it with the X platform, creating a unified engine for social, search, and generative AI. It is not merely a tool—it is an operating system. Latest Valuation: $120B+ Core Products: Grok AI, large-scale AI models, multimodal human–machine interaction Future Highlights: Direct challenge to ChatGPT, AI-powered social platforms, content search, and robotics
Neuralink is developing brain–computer interface systems to restore mobility for paralyzed patients and enable human–AI symbiosis. In 2024, it completed the world’s first human implant and received FDA approval. Elon Musk has called it the “second evolution.” Latest Valuation: $9B+ Core Technologies: Brain–computer interface chips, neural implant surgery robots Future Highlights: Brain restoration, memory enhancement, direct AI connectivity
Date: February 6, 2026
Deployed: USD 28.15 million
+USD 11.23 million
USD 49.29 million
Private equity transactions are often complex, but we choose the safest route forward. From deal structure design and legal review to audit inclusion in financial statements, we apply the rigorous standards of a publicly listed company to cut through every layer of financial opacity.
Signing of LOl / subscription agreement
Acquisition via SPV / private placement
Legal due diligence & third-party valuationreport
SEC disclosure & audit confrmation
Inclusion in fnancialstatements and publicdisclosure
Our investments are in privately held companies, which may have limited liquidity in the short term. Valuations are based on private market assessments and can be significantly affected by macroeconomic conditions. Due to the strong leadership role of Elon Musk, any change in his status could impact valuations.
Multi-round valuation verification mechanism Zero leverage, ensuring strong resilience against market volatility Fully compliant equity acquisition pathways with buyback clauses for added protection
Long-Term Focus: Concentrated positions in assets with high five-year growth potential Conviction-Driven: Committed to backing the most influential drivers of technological transformation Structural Optimization: Ensuring transparent valuations, clear information flow, and sustained growth potential
XMax leverages the structure of a publicly listed company to give everyday investors access to the primary entry point of future-defining industries. The true primary market is no longer out of reach. High-quality assets can withstand the test of time and the power of compounding—such as Elon Musk's ventures SpaceX, xAI, and Neuralink, each with immense future potential.
XMax is committed to connecting global investors with humanity's future technologies—through fully compliant, regulated pathways. As a Nasdaq-listed company (Ticker: XWIN), we continuously disclose our financial and operational information, operating under dual oversight by the SEC and FINRA. This ensures that every investor can make decisions with clarity, transparency, and a long-term value perspective.
